. | . |
US probes claims pharma giants' actions helped Iraq insurgency by Staff Writers Washington (AFP) Aug 1, 2018 US investigators are probing claims AstraZeneca and other medical giants that worked with the Iraqi government between 2005 and 2009 provided drugs and supplies that would go on to be used to fund terror attacks. In a filing with US regulators last week, AstraZeneca said it had received a Department of Justice inquiry "in connection with an anti-corruption investigation relating to activities in Iraq." The filing states the probe is at least partly related to a federal lawsuit filed in October on behalf of troops who were killed or wounded in Iraq in the 2005-2009 period, the height of the Iraq War insurgency. Plaintiffs allege the firms, hoping to win business in Iraq, violated the US Anti-Terrorism Act and other laws by giving pharmaceuticals and medical supplies to the ministry of health when it was controlled by followers of Moqtada Sadr. The powerful Shiite cleric, whose populist coalition triumphed at May elections, at the time ran death squads against Sunnis and is blamed for many attacks on US forces. Sadr's Mahdi Army -- estimated to have had up to 60,000 members -- was once the most active and feared armed Shiite group in Iraq, and was blamed by Washington for thousands of killings. According to The New York Times, the lawsuit claims Sadr's followers sold the medical supplies on Iraq's black market to fund such attacks. Ryan Sparacino, a lawyer for plaintiffs in the case, told AFP on Wednesday that since 2004, "Iranian-backed terrorists have relied on corruption at the Iraqi health ministry to help fund terrorism in Iraq." The lawsuit states the health ministry itself was used to launch attacks, smuggle weapons and gather intelligence, and that ministry employees played key leadership roles in the Mahdi Army. In a statement, AstraZeneca said it "has a robust and dynamic compliance program, and we refuse to tolerate bribery or any other form of corruption." The other firms listed in the lawsuit are General Electric, Johnson & Johnson, Pfizer, as well as Roche Holding A.G. The Department of Justice did not immediately return a request for comment.
Iraq PM sacks electricity minister after weeks of protest Baghdad (AFP) July 29, 2018 Iraqi Prime Minister Haider al-Abadi on Sunday sacked his minister of electricity after three weeks of protests against corruption and chronic power cuts in the energy-rich country. A statement from Abadi's office said the premier sacked Qassem al-Fahdawi - whose departure was demanded by protesters - "because of the deterioration in the electricity sector". Iraq has been gripped by protests over power outages, unemployment, state mismanagement and a lack of clean water. The demonstrations ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |